Male Infertility Market, Male Infertility Market, By Test (DNA Fragmentation Technique, Oxidative, Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay and Others), By Technique (Assisted Reproductive Technology and Medication), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

With a predicted growth rate of 0.80%, the male infertility market, estimated at US$ 4.4 billion in 2024, is expected to reach US$ 7.3 billion by 2034.

Male infertility can be attributed to a number of circumstances, including insufficient sperm production, aberrant sperm blockages, chronic health issues, injuries, illnesses, and other factors that are driving the expansion of the male infertility market. Male infertility is the inability to conceive, which can be upsetting and stressful. The market offers a variety of treatments for male infertility.

The increasing use of assisted reproductive technologies, or ART, has become a significant driver of target market expansion. The rate of male infertility is on the rise, and new, cutting-edge technologies like ICSI (intracytoplasmic sperm injection) have transformed the treatment of severe male infertility and created attractive growth potential for the male infertility market.